ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma.

Daniel V T Catenacci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.